Rowe Price New Asia Fund - I Class Putnam International Capital Opportunities Fund Class A AllianzGI Small-Cap Value Fund Class R PIMCO New York Municipal Bond Class A BNY Mellon New York AMT-Free Municipal Bond Fund Class C PIMCO Fds Pac Inv Mgt Srs NY Muni Bd Fd Insti Cl PIMCO New York Municipal Bond Fund Class I-2 Putnam New York Tax Exempt Income Fund Class R6 Putnam New York Tax Exempt Income Fund Y Shs Pacific Funds Portfolio Optimization Conservative - Class A Pacific Funds Portfolio Optimization Conservative - Class C PRIMECAP Odyssey Aggressive Growth Fund Pacific Funds Portfolio Optimization Moderate-Conservative - Class A Pacific Funds Portfolio Optimization Moderate-Conservative - Class C Pacific Funds Portfolio Optimization Moderate - Class A Pacific Funds Portfolio Optimization Aggressive-Growth - Class C Test Money Market Fund - PICE Pacific Funds Portfolio Optimization Growth - Class A Pacific Funds Portfolio Optimization Growth - Class C Pacific Funds Portfolio Optimization Aggressive-Growth - Class A Pacific Funds Portfolio Optimization Aggressive-Growth - Advisor Class Principal Funds Principal Funds Principal Funds Putnam Growth Opportunities Fund Putnam Growth Opportunities Fund Putnam Growth Opportunities C Shares PRIMECAP Odyssey Growth Fund Pin Oak Equity Fund Putnam Ohio Tax Exempt Income Fund Class R6 Virtus Tactical Allocation Fund Class C Polen International Growth Fund-Institutional Class Polen International Growth Fund-Investor Class Federated Institutional Prime Obligations Fund - IS Class Polen Growth Fund Institutional Class Polen Growth Fund - Investor Class Putnam Mortgage Securities Fund Class R6 Pacific Funds Portfolio Optimization Moderate - Class C Pacific Funds Portfolio Optimization Moderate - Advisor Class Principal Funds Retirement Advantage Maturity Fund Class A T
Hero molecule emphasis: AH-8 (Argireline) for crow's feet expression lines, GHK-Cu for orbital fine-line collagen, multi-MW HA for tear-trough hollowing
The second criterion for establishing a device category, at 419.66(c)(2), provides that CMS determines either of the following: (1) that a device to be included in the category has demonstrated that it will substantially improve the diagnosis or treatment of an illness or injury or improve the functioning of a malformed body part compared to the benefits of a device or devices in a previously established category or other available treatment
Doeppner TR, Kaltwasser B, Elali A, Zechariah A, Hermann DM, Bhr M
Water dissolves many ionic salts thanks to its high dielectric constant and ability to solvate ions
